BioSpace News Archive

The global spina bifida & hydrocephalus market is projected to witness significant growth from 2021 to 2031.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Lubrication is essential to prevent urethral trauma and pain for individuals who self-catheterize.

Vaccentis AG, a clinical-stage Swiss biopharmaceutical company developing patient-specific medicines, announced the appointment of Martin Munte, a veteran leader in biotech and pharma, with extensive executive experience from Amgen, AstraZeneca and Roche, as its new Chief Executive Officer.

July 12, 2022 10:00 UTC Fluke Biomedical announced the OneQA test and workflow automation software now supports the top-selling ProSim 8 multifunction patient simulator.

Wilmington, Delaware, United States, Transparency Market Research Inc.: A hospital-acquired infection is also otherwise known as a nosocomial infection.

Wilmington, Delaware, United States, Transparency Market Research Inc.: One of the primary aspects projected to favorably impact growth of the global haemophilia market growth is increased research and development initiatives, particularly in the area of finding medicinal compounds.

The global cardiovascular and soft tissue repair patches market is expected to witness moderate growth during the forecast period between 2021 and 2031.

According to Transparency Market Research’s latest report on the global pyrogen testing market for the historical period 2017–2018 and forecast period 2019–2027, introduction of pyrogen test in different applications, Increase in new innovative drugs and launch of biologics products and expansion of pharmaceutical and biotechnology industries are projected to drive the global pyrogen testing market during the forecast period

Wilmington, Delaware, United States, Transparency Market Research Inc.: Infertility is the inability of a person to reproduce naturally.

SpyBiotech, a British biotechnology company with a novel vaccine platform technology that can target infectious diseases, cancer, and chronic diseases, has appointed Mark Leuchtenberger as its Chief Executive Officer.